Shares of Biogen Inc. BIIB,
advanced 1.69% to $306.72 on Tuesday, in what proved to be a strong all-around trading session for the stock market, with the S&P 500 SPX Index,
up 1.36% to 4,003.58 and the Dow Jones Industrial Average DJIA,
up 1.18% to 34,098.10. Biogen Inc. hit a new 52-week high, surpassing its previous high of $305.87, which the company reached on Nov. 21.
The stock demonstrated a mixed performance against some of its competitors on Tuesday, such as Johnson & Johnson JNJ,
increased 0.48% to $176.82, Pfizer Inc. PFE,
increased 1.87% to $49.08 and AbbVie Inc. ABBV,
it rose 1.71% to $159.79. Trading volume (867,914) remained 955,869 below its 50-day average volume of 1.8 million.